Corticosteroid (CS) therapy is used by 1% of world population, especially for non-endocrinological indications. Compartmental administration of CS (i.e. topical, inhaled or intraarticular) was developed to prevent undesired effects. Still even these therapies could generate major endocrine syndromes, as our two cases tend to illustrate – Table 1 and Table 2. […]
